A3 Functional decline and frailty

A3 Functional decline and frailty

Abbr: 
A3

The Action Group A3 brings together around 100 organizations, among which public health authorities, care organisations, academia, research centers, industries, patients associations and professional bodies, which have committed themselves to the objectives of understanding the underlying factors of frailty, exploring the association between frailty and adverse health outcomes in older people and better preventing and managing the frailty syndrome and its consequences. These organizations are implementing their own "commitments", which are measurable and concrete activities at local, regional or national level aimed at improving older people health and quality of life.

 

Conclusions from the 2nd day of the Conference of Partners - 28th of February 2018

After an action packed first day, the second day of the conference continued with a plenary session focussing on...

Conclusions from the 1st day of the Conference of Partners - 27th of February 2018

The first day of the 2018 conference of Partners of the EIPonAHA kicked off strongly with Vytenis Andriukaitis,...

Communication on 'Digital Transformation of Health and Care in the Digital Single Market'

Dear EIP Partner,On Wednesday 25 April 2018, the European Commission will adopt the Communication on 'Digital...

4th meeting of the Steering Group on Health Promotion, disease prevention and management of non-communicable diseases

The 4th meeting of the Steering Group on Health Promotion, disease prevention and management of non-communicable...

Best practice portal on health promotion, diseases prevention and management of non-communicable diseases is online now

The best practice portal on health promotion, diseases prevention and management of non-communicable diseases is online...

Main conclusions from the Conference of Partners 2018

370 participants attended the 6th Conference of Partners of the European Innovation Partnership on Active and Health...

Pages

Subscribe to RSS - A3 Functional decline and frailty